Cerus reported $50.81M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Cerus USD 50.81M 4.79M Dec/2024
GRIFOLS EUR 1.98B 110M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Neogen USD 211.2M 13.49M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.37M 30K Dec/2025
Quidel USD 724M 24M Dec/2025
Rockwell Medical USD 25.83M 3.15M Jun/2024
STAAR Surgical USD 239.4M 144.7M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Utah Medical Products USD 9.04M 955K Dec/2025